Mydriasert pupillary dilation for cataract surgery: an economic and clinical study

BACKGROUND: Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to cataract surgery, which gradually releases the active ingredients: tropicamide (0.25 mg) and phenylephrine (5.38 mg). This study aimed to evaluate the cost of Mydriasert compared with conventional mydriatic eye...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Ameet, Johal, Sukhvinder, Lee, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454272/
https://www.ncbi.nlm.nih.gov/pubmed/26036871
http://dx.doi.org/10.1186/s12886-015-0042-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454272/
https://www.ncbi.nlm.nih.gov/pubmed/26036871
http://dx.doi.org/10.1186/s12886-015-0042-y

Ejemplares similares